Bio

Bio


I am a Radiology Resident with future subspecialty interests in MSK, Neuro, and CVI. I also have strong interests in medical education and radiology-pathology correlation.

Honors & Awards


  • Honor Society, Alpha Omega Alpha (2018)
  • Scholar, Frank H. Buck Scholarship (2009)
  • Summer Research Scholarship, Society of Interventional Radiology (2015)
  • Medical Student Travel Scholarship, Society of Interventional Radiology (2015)
  • Academic Excellence and Achievement in Pathology Award, American Society for Clinical Pathology (2015)
  • Honor Society, Intersociety Council for Pathology Information (2016)

Professional Education


  • MD, University of CA, Irvine, Medicine (2018)
  • BS, Stanford University, Biology, History (2013)

Publications

All Publications


  • The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma. Clinical imaging Smolka, S., Chapiro, J., Manzano, W., Treilhard, J., Reiner, E., Deng, Y., Zhao, Y., Hamm, B., Duncan, J. S., Gebauer, B., Lin, M., Geschwind, J. F. 2017; 46: 1?7

    Abstract

    To investigate whether bevacizumab compromises early response assessment after Transarterial Chemoembolization (TACE) in patients with hepatocellular carcinoma by 3D quantitative European Association for the Study of the Liver (qEASL) criteria in comparison to other imaging-based criteria.Each of 14 patients receiving TACE and bevacizumab was matched with two patients receiving TACE alone. Baseline and Follow-up MRI was retrospectively analyzed regarding qEASL and other imaging-based criteria.Percentage-based qEASL achieved significant separation in both therapy arms (p=0.046 and p=0.015). Response and Overall Survival showed similar association among treatment groups (p=0.749).Anti-angiogenic therapy with bevacizumab does not impede early response assessment by qEASL.

    View details for DOI 10.1016/j.clinimag.2017.05.007

    View details for PubMedID 28668723

    View details for PubMedCentralID PMC5720941

  • Bone mineral density loss in thoracic and lumbar vertebrae following radiation for abdominal cancers. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Wei, R. L., Jung, B. C., Manzano, W., Sehgal, V., Klempner, S. J., Lee, S. P., Ramsinghani, N. S., Lall, C. 2016; 118 (3): 430?36

    Abstract

    To investigate the relationship between abdominal chemoradiation (CRT) for locally advanced cancers and bone mineral density (BMD) reduction in the vertebral spine.Data from 272 patients who underwent abdominal radiation therapy from January 1997 to May 2015 were retrospectively reviewed. Forty-two patients received computed tomography (CT) scans of the abdomen prior to initiation and at least twice after radiation therapy. Bone attenuation (in Hounsfield unit) (HU) measurements were collected for each vertebral level from T7 to L5 using sagittal CT images. Radiation point dose was obtained at each mid-vertebral body from the radiation treatment plan. Percent change in bone attenuation (?%HU) between baseline and post-radiation therapy were computed for each vertebral body. The ?%HU was compared against radiation dose using Pearson's linear correlation.Abdominal radiotherapy caused significant reduction in vertebral BMD as measured by HU. Patients who received only chemotherapy did not show changes in their BMD in this study. The ?%HU was significantly correlated with the radiation point dose to the vertebral body (R=-0.472, P<0.001) within 4-8 months following RT. The same relationship persisted in subsequent follow up scans 9 months following RT (R=-0.578, P<0.001). Based on the result of linear regression, 5 Gy, 15 Gy, 25 Gy, 35 Gy, and 45 Gy caused 21.7%, 31.1%, 40.5%, 49.9%, and 59.3% decrease in HU following RT, respectively. Our generalized linear model showed that pre-RT HU had a positive effect (?=0.830) on determining post-RT HU, while number of months post RT (?=-0.213) and radiation point dose (?=-1.475) had a negative effect. A comparison of the predicted versus actual HU showed significant correlation (R=0.883, P<0.001) with the slope of the best linear fit=0.81. Our model's predicted HU were within 20 HU of the actual value in 53% of cases, 70% of the predictions were within 30 HU, 81% were within 40 HU, and 90% were within 50 HU of the actual post-RT HU. Four of 42 patients were found to have vertebral body compression fractures in the field of radiation.Patients who receive abdominal chemoradiation develop significant BMD loss in the thoracic and lumbar vertebrae. Treatment-related BMD loss may contribute to the development of vertebral compression fractures. A predictive model for post-CRT BMD changes may inform bone protective strategies in patients planned for abdominal CRT.

    View details for DOI 10.1016/j.radonc.2016.03.002

    View details for PubMedID 26993414

  • Augmenting endogenous Wnt signaling improves skin wound healing. PloS one Whyte, J. L., Smith, A. A., Liu, B., Manzano, W. R., Evans, N. D., Dhamdhere, G. R., Fang, M. Y., Chang, H. Y., Oro, A. E., Helms, J. A. 2013; 8 (10)

    Abstract

    Wnt signaling is required for both the development and homeostasis of the skin, yet its contribution to skin wound repair remains controversial. By employing Axin2(LacZ/+) reporter mice we evaluated the spatial and temporal distribution patterns of Wnt responsive cells, and found that the pattern of Wnt responsiveness varies with the hair cycle, and correlates with wound healing potential. Using Axin2(LacZ/LacZ) mice and an ear wound model, we demonstrate that amplified Wnt signaling leads to improved healing. Utilizing a biochemical approach that mimics the amplified Wnt response of Axin2(LacZ/LacZ) mice, we show that topical application of liposomal Wnt3a to a non-healing wound enhances endogenous Wnt signaling, and results in better skin wound healing. Given the importance of Wnt signaling in the maintenance and repair of skin, liposomal Wnt3a may have widespread application in clinical practice.

    View details for DOI 10.1371/journal.pone.0076883

    View details for PubMedID 24204695

Footer Links:

Stanford Medicine Resources: